Nothing Special   »   [go: up one dir, main page]

PA8532001A1 - Bifenilcarboxamidas utiles como agentes reductores de lipidos - Google Patents

Bifenilcarboxamidas utiles como agentes reductores de lipidos

Info

Publication number
PA8532001A1
PA8532001A1 PA20018532001A PA8532001A PA8532001A1 PA 8532001 A1 PA8532001 A1 PA 8532001A1 PA 20018532001 A PA20018532001 A PA 20018532001A PA 8532001 A PA8532001 A PA 8532001A PA 8532001 A1 PA8532001 A1 PA 8532001A1
Authority
PA
Panama
Prior art keywords
bifenyl
carboxamids
useful
reducing agents
lipid reducing
Prior art date
Application number
PA20018532001A
Other languages
English (en)
Inventor
Leo Jacobus Jozef Backx
Lieven Meerpoel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PA8532001A1 publication Critical patent/PA8532001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

COMPUESTOS DE BIFENILCARBOXAMIDA DE FORMULA (I) METODOS PARA PREPARAR TALES COMPUESTOS, COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN DICHOS COMPUESTOS COMO ASI TAMBIEN EL USO DE DICHOS COMPUESTOS COMO UN MEDICAMENTO PARA EL TRATAMIENTO DE LA HIPERLIPIDEMIA, LA OBESIDAD Y LA DIABETES TIPO II.
PA20018532001A 2000-11-21 2001-11-09 Bifenilcarboxamidas utiles como agentes reductores de lipidos PA8532001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204150 2000-11-21

Publications (1)

Publication Number Publication Date
PA8532001A1 true PA8532001A1 (es) 2002-10-28

Family

ID=8172315

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018532001A PA8532001A1 (es) 2000-11-21 2001-11-09 Bifenilcarboxamidas utiles como agentes reductores de lipidos

Country Status (32)

Country Link
US (5) US7135586B2 (es)
EP (1) EP1339685B1 (es)
JP (1) JP4190283B2 (es)
KR (1) KR20030051718A (es)
CN (1) CN1289481C (es)
AR (1) AR035072A1 (es)
AT (1) ATE344243T1 (es)
AU (2) AU2002219115B2 (es)
BG (1) BG107805A (es)
CA (1) CA2427660C (es)
CZ (1) CZ20031638A3 (es)
DE (1) DE60124296T2 (es)
DK (1) DK1339685T3 (es)
EA (1) EA006101B1 (es)
EE (1) EE200300234A (es)
ES (1) ES2275759T3 (es)
GC (1) GC0000312A (es)
HK (1) HK1073310A1 (es)
HU (1) HUP0400926A3 (es)
IL (2) IL155945A0 (es)
JO (1) JO2409B1 (es)
MX (1) MXPA03004465A (es)
MY (1) MY134167A (es)
NO (1) NO20032272D0 (es)
NZ (1) NZ526495A (es)
PA (1) PA8532001A1 (es)
PL (1) PL205290B1 (es)
PT (1) PT1339685E (es)
SI (1) SI1339685T1 (es)
SK (1) SK7522003A3 (es)
WO (1) WO2002042271A2 (es)
ZA (1) ZA200303910B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
WO2002098839A1 (fr) * 2001-06-01 2002-12-12 Tanabe Seiyaku Co., Ltd. Biphenylcarboxamides et procede de preparation de ceux-ci
CN101838218A (zh) 2002-02-28 2010-09-22 日本烟草产业株式会社 酯化合物及其医药用途
PL205531B1 (pl) 2002-03-13 2010-04-30 Janssen Pharmaceutica Nv Pochodna karbonyloaminowa, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
ATE424395T1 (de) 2002-03-13 2009-03-15 Janssen Pharmaceutica Nv Aminoderivate als histone-deacetylase-inhibitoren
UA79300C2 (en) * 2002-08-12 2007-06-11 Janssen Pharmaceutica Nv N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
EP1581499A1 (en) * 2002-12-20 2005-10-05 Pfizer Products Inc. Microsomal triglyceride transfer protein inhibitors
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2005021486A1 (ja) 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
FR2871463B1 (fr) * 2004-06-11 2006-09-22 Merck Sante Soc Par Actions Si Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
MX2007001120A (es) 2004-07-28 2007-03-15 Janssen Pharmaceutica Nv Derivados de indolil alquil sustituidos como nuevos inhibidores de la histona desacetilasa.
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
WO2007053436A1 (en) 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
WO2007082874A1 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2009006185A1 (en) * 2007-07-03 2009-01-08 Janssen Pharmaceutica, N.V. Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
US10491357B2 (en) * 2010-07-12 2019-11-26 Entropic Communications Llc Method and apparatus for using dynamic subchannels in a communications network

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
US3929801A (en) 1973-11-20 1975-12-30 Janssen Pharmaceutica Nv 2-Benzimidazolinones
US3929601A (en) * 1974-03-26 1975-12-30 Us Energy Synthesis of pentafluorides
DE2852203C3 (de) * 1978-12-02 1982-03-11 Ibm Deutschland Gmbh, 7000 Stuttgart Lichtleiteinrichtung für eine mit Auflicht betriebene Abbildungsvorrichtung
US4231576A (en) * 1979-02-21 1980-11-04 Perkins Sonnie J Golf club head alignment apparatus
US4329348A (en) 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444764A (en) * 1979-08-06 1984-04-24 The Dow Chemical Company Phosphorus esters of alkylcycloalkyl-5-pyrimidinols and control of corn rootworm and western spotted cucumber beetle with them
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
DE3124366A1 (de) 1981-06-20 1982-12-30 Hoechst Ag, 6000 Frankfurt N-oxacyclyl-alkylpiperidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US4739073A (en) 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE3410498A1 (de) * 1984-03-22 1985-10-03 Hoechst Ag, 6230 Frankfurt N-bicycloheptyl- und n-bicycloheptenyl-imidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate
US4647576A (en) 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4847271A (en) 1986-01-27 1989-07-11 Merck & Co., Inc. Antihypercholesterolemic β-lactones
US5041432A (en) 1987-01-30 1991-08-20 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
GB8716059D0 (en) * 1987-07-08 1987-08-12 Anderson Strathclyde Plc Mining machine
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5064858A (en) * 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US5064856A (en) 1989-07-31 1991-11-12 Merck & Co., Inc. Novel hmg-coa synthase inhibitors
US5120729A (en) 1990-06-20 1992-06-09 Merck & Co., Inc. Beta-lactams as antihypercholesterolemics
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
DE4040203A1 (de) 1990-12-15 1992-06-17 Roehm Gmbh Eingetruebte kunststoffelemente
AU1970892A (en) * 1991-04-18 1992-11-17 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
DE4140540A1 (de) 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
WO1993011782A1 (en) 1991-12-19 1993-06-24 Southwest Foundation For Biomedical Research Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
US5595872A (en) 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
ZA931601B (en) 1992-03-06 1993-10-05 Squibb & Sons Inc Microsomal triglyceride transfer protein
EP0567026B1 (en) 1992-04-20 2003-03-26 Takeda Chemical Industries, Ltd. 4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides
US5279454A (en) 1992-04-24 1994-01-18 Eastman Kodak Company Straight through lateral constraint
US5327875A (en) * 1993-02-19 1994-07-12 Hall S Franklin Vapor enhanced carburetion system
DE4319038A1 (de) 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
US5780248A (en) * 1993-07-15 1998-07-14 Ortho Diagnostic Systems, Inc. Foil sealed cassette for agglutination reactions and liner therefor
FI93396C (fi) 1993-08-17 1995-03-27 Petetronic Tmi P Kinnunen Optinen menetelmä nesteen pinnankorkeuden mittaamiseksi
SK282402B6 (sk) 1993-08-19 2002-01-07 Janssen Pharmaceutica N. V. Deriváty dihydrobenzopyránu, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutický prostriedok na ich báze
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
AU678503B2 (en) 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
CZ286403B6 (en) * 1993-12-07 2000-04-12 S & R Maschb Gmbh Apparatus for baking pies
JPH086412A (ja) * 1994-06-20 1996-01-12 Canon Inc 加熱装置および画像形成装置
AU3577995A (en) 1994-10-04 1996-04-26 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
US5510379A (en) 1994-12-19 1996-04-23 Warner-Lambert Company Sulfonate ACAT inhibitors
US5536859A (en) 1995-02-27 1996-07-16 Amoco Corporation Alpha-olefin catalyst and process
GB9504066D0 (en) 1995-03-01 1995-04-19 Pharmacia Spa Phosphate derivatives of ureas and thioureas
US5541199A (en) 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
WO1996040640A1 (en) 1995-06-07 1996-12-19 Pfizer Inc. BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
US5919795A (en) 1995-06-07 1999-07-06 Pfizer Inc. Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion
US5696196A (en) * 1995-09-15 1997-12-09 Egyptian Lacquer Mfg. Co. EMI/RFI-shielding coating
US5827875A (en) 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
DE59708572D1 (de) 1996-09-03 2002-11-28 Siemens Ag Anordnung und verfahren zur kryptographischen bearbeitung eines digitalen datenstroms, der eine beliebige anzahl von daten aufweist
FR2756027B1 (fr) 1996-11-15 1999-01-15 Dimos Crochet de securite
KR100334567B1 (ko) * 1996-11-27 2002-05-03 디. 제이. 우드, 스피겔 알렌 제이 아포 비-분비/엠티피 억제성 아미드
DE19649751C2 (de) 1996-11-30 1999-12-30 Cts Fahrzeug Dachsysteme Gmbh Dachaufbau für Fahrzeuge, insbesondere Personenkraftwagen
US5876070A (en) 1996-12-11 1999-03-02 Kennecott Holdings Corporation Pipe flange connection for pressure retaining, abrasive/corrosive service
GB9626045D0 (en) 1996-12-14 1997-01-29 Rover Group A vehicle roll stabilising system
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
AU5513298A (en) 1996-12-20 1998-07-17 Bristol-Myers Squibb Company Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
US5966677A (en) 1997-02-28 1999-10-12 Fiekowsky; Peter J. High accuracy particle dimension measurement system
GB9705206D0 (en) 1997-03-13 1997-04-30 Automotive Prod Italia Drum brakes
US5968950A (en) 1997-06-23 1999-10-19 Pfizer Inc Apo B-secretion/MTP inhibitor hydrochloride salt
US5988950A (en) * 1997-11-18 1999-11-23 Atlantic Richfield Company Method and system for preventing upward migration of contaminants in soil
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
GB9725782D0 (en) 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
US5989950A (en) * 1998-01-26 1999-11-23 Texas Instruments - Acer Incorporated Reduced mask CMOS salicided process
US6173351B1 (en) 1998-06-15 2001-01-09 Sun Microsystems, Inc. Multi-processor system bridge
US6133217A (en) 1998-08-28 2000-10-17 Huntsman Petrochemical Corporation Solubilization of low 2-phenyl alkylbenzene sulfonates
US5985577A (en) * 1998-10-14 1999-11-16 The Trustees Of Columbia University In The City Of New York Protein conjugates containing multimers of green fluorescent protein
GB9826412D0 (en) * 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds
WO2000032532A1 (en) 1998-12-03 2000-06-08 Lucio Alvaro Process for thermal treatment of inorganic and organic materials in a series of small shafts, and the apparatus to perform ditto process
DK1187829T3 (da) 1999-06-02 2004-04-13 Janssen Pharmaceutica Nv Aminoalkylsubstituerede (benzodioxan, benzofuran eller benzopyran) derivater
CZ20014167A3 (cs) 1999-06-02 2002-06-12 Janssen Pharmaceutica N. V. Pyrrolidinylem, piperidinylem nebo homopiperidinylem substituované deriváty benzodioxanu, benzofuranu nebo benzopyranu
AU2001262185A1 (en) 2000-04-10 2001-10-23 Novartis Ag Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
JO2352B1 (en) 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents
WO2002081480A1 (en) 2001-04-09 2002-10-17 Eli Lilly And Company Compounds and pharmaceutical compositions for inhibiting mrp1
GB0423422D0 (en) * 2004-10-21 2004-11-24 Bard Inc C R Medical device for fluid flow, and method of forming such device

Also Published As

Publication number Publication date
EA006101B1 (ru) 2005-08-25
PT1339685E (pt) 2007-02-28
NO20032272L (no) 2003-05-20
US20060128973A1 (en) 2006-06-15
CA2427660C (en) 2010-01-19
WO2002042271A3 (en) 2002-11-21
HUP0400926A3 (en) 2008-03-28
US7405307B2 (en) 2008-07-29
NO20032272D0 (no) 2003-05-20
JP4190283B2 (ja) 2008-12-03
US20060128972A1 (en) 2006-06-15
ATE344243T1 (de) 2006-11-15
HUP0400926A2 (hu) 2004-07-28
PL205290B1 (pl) 2010-03-31
US20080009522A1 (en) 2008-01-10
IL155945A (en) 2009-06-15
US7538124B2 (en) 2009-05-26
CN1289481C (zh) 2006-12-13
CA2427660A1 (en) 2002-05-30
EP1339685B1 (en) 2006-11-02
CN1568312A (zh) 2005-01-19
ES2275759T3 (es) 2007-06-16
US7244848B2 (en) 2007-07-17
EE200300234A (et) 2003-08-15
DE60124296T2 (de) 2007-05-31
JO2409B1 (en) 2007-06-17
MXPA03004465A (es) 2003-08-19
AR035072A1 (es) 2004-04-14
ZA200303910B (en) 2004-09-01
US20080275087A1 (en) 2008-11-06
GC0000312A (en) 2006-11-01
CZ20031638A3 (cs) 2004-02-18
AU1911502A (en) 2002-06-03
SK7522003A3 (en) 2004-04-06
US20040102490A1 (en) 2004-05-27
PL361633A1 (en) 2004-10-04
US7304167B2 (en) 2007-12-04
WO2002042271A2 (en) 2002-05-30
JP2004521870A (ja) 2004-07-22
SI1339685T1 (sl) 2007-04-30
KR20030051718A (ko) 2003-06-25
EP1339685A2 (en) 2003-09-03
AU2002219115B2 (en) 2007-01-04
MY134167A (en) 2007-11-30
DK1339685T3 (da) 2007-03-12
US7135586B2 (en) 2006-11-14
EA200300597A1 (ru) 2003-10-30
BG107805A (bg) 2004-01-30
IL155945A0 (en) 2003-12-23
NZ526495A (en) 2004-06-25
HK1073310A1 (en) 2005-09-30
DE60124296D1 (de) 2006-12-14

Similar Documents

Publication Publication Date Title
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
UY27740A1 (es) Nuevos compuestos
UY29004A1 (es) Compuestos derivados sustituídos de ácidos, glicina y alanina; procedimiento para su preparación y uso.
UY28374A1 (es) Agentes terapéuticos
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY28482A1 (es) Nuevos compuestos
UY28342A1 (es) Nuevos compuestos
UY28800A1 (es) 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos
UY28369A1 (es) Agentes terapéuticos
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
UY28150A1 (es) Agentes terapeuticos
UY28144A1 (es) Agentes terapéuticos
BR0310077A (pt) Novos compostos e sua utilização
UY30736A1 (es) Compuestos quimicos 537
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR034120A1 (es) Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
UY28377A1 (es) Agentes terapeuticos